Biopharma Daily Stock Updates - 02/04/21

$XBI $162.77 +1%

COVID:

$DVAX +2% Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization

$AGEN +18% Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19

PIPELINE:

$ALDX +6% Aldeyra Therapeutics Announces Phase 3 TRANQUILITY Dry Eye Disease Trial Design

FINANCIAL:

$SIOX +2% Sio Gene Therapies Announces Receipt of $11.6 Million from Closing of the Sale of Arvelle Therapeutics

$EQ +17% Equillium Announces Pricing of $30 Million Registered Direct Offering

$DRRX -15% DURECT Corporation Announces Pricing of $42.5 Million Public Offering of Common Stock